Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported on Monday (NASDAQ:MNDY ...

Misconceptions about the influenza and COVID-19 vaccines may make some people ... "You aren't going to get the flu from the ...

Increased capabilities for genomic surveillance have offered new insights into global viral evolution. Seasonal flu showed a 'remarkable' bounce back to pre-pandemic levels once international air ...

On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...

The drop is a “concerning trend and highlights missed opportunities” to prevent influenza-related complications, the study ...

The flu vaccine benefits you by protecting you and the people you live with or spend significant time around. Everyone 6 ...

And, says the health authority, you can get both shots at once and save a trip. "People will have the opportunity to receive ...

Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...

The authors said the main outcomes of the study were reactogenicity, including fever, chills, muscle aches, and/or joint pain ...